Literature DB >> 15293526

Leptin and biochemical markers of bone turnover in dialysis patients.

Carmine Zoccali1, Vincenzo Panuccio, Giovanni Tripepi, Sebastiano Cutrupi, Patrizia Pizzini, Francesca Mallamaci.   

Abstract

BACKGROUND AND
OBJECTIVE: The adipose tissue cytokine leptin is suggested to interfere with bone turnover mechanisms because, in rats with leptin deficiency, intra-cerebroventricular administration of this cytokine causes a reduction in bone mass. We studied the relationship between plasma leptin and biochemical bone turnover indicators in 161 hemodialysis (HD) patients.
RESULTS: Plasma leptin was sex-dependent, being significantly higher (p<0.001 ) in female dialysis patients than in male dialysis patients, and it related directly to body mass index (BMI). In males, plasma leptin related inversely to serum intact parathyroid (PTH) (partial r= -0.34), serum PTH(1-84) (r= -0.36), carboxyterminal PTH (C-PTH) fragment (r= -0.31) and serum PTH(1-84)/C-PTH fragment ratio (r= -0.22), while no such relationships were found in females. Of 93 male dialysis patients, 44 had a serum intact PTH <100 pg/mL and 14 had a serum PTH(1-84)/C-PTH fragment ratio <1. In a multiple logistic regression analysis in males, for each 1 ng/mL increase in plasma leptin there was an 11% excess risk of serum intact PTH <100 pg/mL (odds ratio (OR) 1.11, 95% confidence interval (95% CI): 1.02-1.20, p=0.01) and a similar OR was found when low bone turnover was defined based on a serum PTH(1-84)/C-PTH fragment ratio <1 (p=0.01). In addition, plasma leptin related inversely to skeletal alkaline phosphatase and again this relationship was found in male but not in female dialysis patients.
CONCLUSIONS: Our data support the theory that leptin reduces bone turnover in male dialysis patients. Whether this link underlies a noxious or a protective mechanism, i.e. if it can serve to limit high bone turnover due to hyperparathyroidism, remains to be established in prospective studies based on solid outcome measures like the risk of fractures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293526

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  10 in total

Review 1.  Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition.

Authors:  Jingjing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-12-14       Impact factor: 2.370

Review 2.  The intriguing connections of leptin to hyperparathyroidism.

Authors:  Stergios A Polyzos; Leonidas Duntas; Jens Bollerslev
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

Review 3.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

4.  Correction of metabolic acidosis in hemodialysis: consequences on serum leptin and mineral metabolism.

Authors:  Alessandra M Bales; Rosa M A Moysés; Luciene M dos Reis; Fabiana G Graciolli; James Hung; Manuel Carlos Martins Castro; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2014-09-25       Impact factor: 2.370

5.  Associations between serum leptin level and bone turnover in kidney transplant recipients.

Authors:  Csaba P Kovesdy; Miklos Z Molnar; Maria E Czira; Anna Rudas; Akos Ujszaszi; Laszlo Rosivall; Miklos Szathmari; Adrian Covic; Andras Keszei; Gabriella Beko; Peter Lakatos; Janos Kosa; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

6.  Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism.

Authors:  Daniel Antonio de Luis; Gonzalo Diaz Soto; Rosa Conde; Olatz Izaola; Beatriz de la Fuente
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

7.  Correlation of serum leptin with levels of hemoglobin in hemodialysis.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri
Journal:  J Nephropharmacol       Date:  2012-07-01

8.  Association of serum leptin with serum C-reactive protein in hemodialysis patients.

Authors:  Ebrahim Rastegari; Hamid Nasri
Journal:  J Nephropharmacol       Date:  2012-07-01

9.  Renal osteodystrophy in the obesity era: Is metabolic syndrome relevant?

Authors:  Janaina Da Silva Martins; João Henrique Castro; Nestor A Sainz Rueda; Luciene Machado Dos Reis; Vanda Jorgetti; Rosa Maria Affonso Moysés; Jacqueline Teixeira Caramori
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

10.  Correlation between serum leptin and bone mineral density in hemodialysis patients.

Authors:  Mahin Ghorban-Sabbagh; Fatemeh Nazemian; Massih Naghibi; Mohammad-Taghi Shakeri; Saeedeh Ahmadi-Simab; Reza Javidi-Dasht-Bayaz
Journal:  J Renal Inj Prev       Date:  2016-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.